Search
Now showing items 1-10 of 12
Preprint
Evaluation of super-boosted lopinavir/ritonavir in combination with rifampicin in HIV-1-infected patients with tuberculosis
| Date Issued:
2020 | Copyright:
open access
Article
Daily 800 mg versus 600 mg Efavirenz for HIV patients treating tuberculosis with a Rifampicin-based regimen: an open label randomized controlled trial
| Date Issued:
2018 | Copyright:
open access
Article
RePORT International: Advancing tuberculosis biomarker research through global collaboration
| Date Issued:
2015 | Copyright:
open access
Article
Accuracy of determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units
| Date Issued:
2019 | Copyright:
open access
Article
T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens
| Date Issued:
2013 | Copyright:
open access
Article
Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults
| Date Issued:
2018 | Copyright:
open access
Article
Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro
| Date Issued:
2007 | Copyright:
open access
Article
A side-by-side comparison of T cell reactivity to fifty-nine mycobacterium tuberculosis antigens in diverse populations from five continents
| Date Issued:
2015 | Copyright:
restricted access
Article
Pharmacological interaction of lopinavir/ritonavir 800/200 mg BID and rifampicin in subjects presenting tuberculosis with contraindication for an efavirenz containing antiretroviral regimen
| Date Issued:
2014 | Copyright:
open access
Article
Determinants of losses in the latent tuberculosis infection cascade of care in Brazil
| Date Issued:
2021 | Copyright:
open access